The Clinical Efficacy of Belting Stabilization for Shoulder Pain

July 9, 2013 updated by: Dr. Helen Razmjou, Sunnybrook Health Sciences Centre

The Clinical Efficacy of Belting Stabilization for Shoulder Pain: A Double Blinded Randomized Clinical Trial

Application of a belt for stabilization while exercising accelerate and optimize recovery in patients diagnosed with shoulder impingement syndrome.

Study Overview

Detailed Description

Stabilization through belts is commonly used as an adjunct for treatment of musculoskeletal problems. Although this treatment is popular among clinicians, there is a paucity of evidence on its use for shoulder pathology. The objective of this double-blinded longitudinal randomized controlled trial (RCT) is to determine the clinical efficacy of stabilization belting applied to patients receiving rehabilitation treatment for shoulder impingement syndrome. The study population will include patients who have been referred to the physiotherapy department of the Holland Orthopaedic & Arthritic Centre for conservative treatment. Patients will be randomized into the treatment and control groups. The primary outcome measure is the Quick Disabilities of Arm, Shoulder and Hand (QuickDASH) questionnaire.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M4Y 1H1
        • Holland Orthopaedic and Arthritic Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of impingement syndrome or post-surgical stiffness with an abnormal scapulothoracic rhythm

Exclusion Criteria:

  • Inability to speak or read English
  • Evidence of major joint trauma causing fracture
  • Infection
  • Underlying metabolic or inflammatory disease
  • Avascular necrosis
  • Frozen shoulder
  • Major medical illness
  • Psychiatric illness that precluded informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: True Stabilization Group
Patients will be randomized to one of the two treatment groups (true stabilization vs. sham stabilization). Patients will be exercising with a belt that is expected to reduce impingement of the rotator cuff tendons.
Patients receive true stabilization.
Other Names:
  • Belt Stabilization
Patients receive sham stabilization.
Other Names:
  • Ineffective stabilization
Sham Comparator: Sham Stabilization
Patients receive sham stabilization. The sham procedure imitates the treatment without any true effect.
Patients receive true stabilization.
Other Names:
  • Belt Stabilization
Patients receive sham stabilization.
Other Names:
  • Ineffective stabilization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The Primary outcome measure is a subjective measure, the Quick Disability of the Arm, Shoulder and Hand (QuickDASH)
Time Frame: Outcome measures are collected before the initial treatment, at 3 weeks, and at 6 weeks following the initial treatment
Outcome measures are collected before the initial treatment, at 3 weeks, and at 6 weeks following the initial treatment

Secondary Outcome Measures

Outcome Measure
Time Frame
The secondary subjective outcomes include a joint specific measure, the American shoulder and Elbow Surgeons (ASES) score, and the work limitation questionnaire (WLQ-25).
Time Frame: Outcome measures are collected before the initial treatment, at 3 weeks, and at 6 weeks following the initial treatment
Outcome measures are collected before the initial treatment, at 3 weeks, and at 6 weeks following the initial treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Helen Razmjou, PhD, Sunnybrook Health Sciences Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2009

Primary Completion (Actual)

May 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

January 20, 2009

First Submitted That Met QC Criteria

January 21, 2009

First Posted (Estimate)

January 22, 2009

Study Record Updates

Last Update Posted (Estimate)

July 11, 2013

Last Update Submitted That Met QC Criteria

July 9, 2013

Last Verified

July 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Impingement Syndrome

Clinical Trials on Stabilization belt

3
Subscribe